In recent years, blockbuster drugs, such as semaglutide (Ozempic, Rybelsus), tirzepatide (Mounjaro), and liraglutide (Victoza), have received growing attention as promising drugs for the treatment of type 2 diabetes and obesity
#Healthcare #Pharma #Semaglutide #Ozempic #WeightLoss #Diabetes #StartupIndia #HealthTech To view or add a comment, sign in Indias Pharma Industry is entering a **Gold Rush phase** and this time, its driven by **Semaglutide**
GLP-1 agonists are not suitable for everyone and there are specific criteria you will need to meet to get a prescription
People with high-sugar diets can become resistant to insulin eventually, this can develop into type 2 diabetes
Get personalised support for managing your weight loss treatment with existing health conditions